TMS to help recovery in people with opioid and alcohol use disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares three approaches in an intensive outpatient setting: treatment as usual (TAU), TAU plus a 3-minute Theta Burst Stimulation TMS session each morning, and TAU plus a 9-minute TMS session each morning, over four weeks. The goal is to see if TMS can improve consumption, cravings, withdrawal symptoms, overall health, sleep, cognitive function, and engagement with therapy. The study is conducted at Another Chance Rehab in Portland, with Washington State University as the lead sponsor. Participants are adults with both opioid use disorder and/or alcohol use disorder who are in an intensive outpatient program and meet the eligibility criteria. Safety and outcome measures will be collected through specified surveys and clinical assessments.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18+ years old
* Enrolled in the Intensive Outpatient Program at Another Chance Drug \& Alcohol Rehab Center of Portland, Portland, OR.
* Diagnosed with Opioid Use Disorder
* Diagnosed with Alcohol Use Disorder

Exclusion Criteria:

* Children \<18 years old
* Pregnant
* Non-English speaking
* Currently taking prescription benzodiazepines or anti-convulsive medications
* In active alcohol or opioid withdrawal
* History of seizure disorder diagnosis
* History of Schizophrenia, Bipolar Disorder, Mania

Where it's running

• Another Chance Drug & Alcohol Rehab Center of Portland
  Portland, Oregon, United States Recruiting

Study contacts

• Principal investigator: Matthew E Layton, MD, PhD — Washington State University
• Study coordinator: Matthew E Layton, MD, PhD
• Email: layton@wsu.edu
• Phone: 509-389-1108

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Brief alcohol-focused program tailored for people taking buprenorphine

  This project will try a short, opioid-informed alcohol counseling program for adults on prescribed buprenorphine who drink alcohol to see if it reduces drinking and helps them stay in treatment.

  Recruiting University of Notre Dame · Notre Dame, Indiana · NCT07342504

• Impact of MOUD Policy Changes During the Pandemic on Opioid and Alcohol Use Disorders

  This study tests how federal and state policy changes during the COVID-19 pandemic affected access to and use of medications for opioid use disorder among Veterans with opioid or alcohol use disorders.

  Recruiting Boston University · Boston, Massachusetts · NCT07232641

• Engagement of community health workers to support recovery from substance use disorders

  This study is testing whether support from community health workers can help people with substance use disorders engage better in treatment and improve their recovery experience after visiting the emergency department.

  Recruiting University of California, Los Angeles · Providence, Rhode Island · NCT06320015

• Translating and validating a questionnaire for opioid misuse in Swedish pain patients

  This study is testing a new Swedish questionnaire to see if it can help identify opioid misuse among pain patients who are using opioids for treatment.

  Recruiting Uppsala University · Uppsala, Uppland · NCT06084520

• Community partnerships to address the opioid crisis

  This study is testing a new online program that helps people recovering from opioid use disorder fix small legal issues that might be holding them back.

  Recruiting at 2 sites University of Michigan · Ann Arbor, Michigan and 1 other locations · NCT05665179

• Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures

  This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.

  Recruiting Université Catholique de Louvain · Brussels, Belgium · NCT07925281

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.